SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-092578
Filing Date
2022-08-18
Accepted
2022-08-18 16:40:44
Documents
2
Period of Report
2022-08-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2224109-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2224109-1_4seq1.xml 4 8242
2 EXHIBIT 24 tm2224109-1_ex24.htm EX-24 9046
  Complete submission text file 0001104659-22-092578.txt   18704
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
MISRA TUSHAR (Reporting) CIK: 0001877233 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38129 | Film No.: 221177904